Tilray Brands, Inc. (TLRY) Registers a Bigger Fall Than the Market: Important Facts to Note

Company Performance - Tilray Brands, Inc. (TLRY) stock decreased by 2.46% to $1.19, underperforming the S&P 500 which fell by 0.1% [1] - Over the past month, Tilray's shares appreciated by 15.09%, outperforming the Medical sector's gain of 0.86% and the S&P 500's gain of 2.57% [1] Earnings Expectations - Analysts expect Tilray to report earnings of -$0.03 per share, indicating a year-over-year growth of 25% [2] - The consensus estimate for revenue is $206.83 million, reflecting a 3.39% increase compared to the same quarter last year [2] Fiscal Year Projections - For the entire fiscal year, earnings are projected at -$0.11 per share, representing a change of -1200% from the prior year [3] - Revenue for the fiscal year is estimated at $877.28 million, indicating a growth of 6.81% from the previous year [3] Analyst Estimates and Rankings - Recent changes in analyst estimates for Tilray are important as they reflect short-term business trends and can indicate a favorable outlook on business health and profitability [4] - The Zacks Rank system, which evaluates estimate changes, currently ranks Tilray as 3 (Hold) [6] Industry Context - The Medical - Products industry, which includes Tilray, ranks in the top 36% of all industries according to the Zacks Industry Rank [7] - The top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]